Angiotensin II receptor mRNA expression and vasoconstriction in human coronary arteries: Effects of heart failure and age

Basic and Clinical Pharmacology and Toxicology

Volumn 95, Issue 6, 2004, Pages 266-272

  Wackenfors, Angelica ^a,b   Pantev, Emil ^a   Emilson, Malin ^a   Edvinsson, Lars ^a   Malmsjö, Malin ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; MESSENGER RNA;

AGE; AGING; ARTERY CONSTRICTION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY; DOWN REGULATION; HEART FAILURE; HUMAN; HUMAN TISSUE; HYPERTENSION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DENSITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN II; CARDIAC OUTPUT, LOW; CASE-CONTROL STUDIES; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASOCONSTRICTION;

EID: 10644223448     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2004.t01-1-pto950504.x     Document Type: Article

References (32)

1. Akishita, M., M. Horiuchi, H. Yamada, L. Zhang, G. Shirakami, K. Tamura, Y. Ouchi & V. J. Dzau: Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol Genomics 2000, 2, 13-20.
2. Belmin, J., B. I. Levy & J. B. Michel: Changes in the renin-angiotensin-aldosterone axis in later life. Drugs Aging 1994, 5, 391-400.
3. Black, J. W. & P. Leff: Operational models of pharmacological agonism. Proc. Royal Soc. Lond. B Biol. Sci. 1983, 220, 141-162.
4. Carey, R. M., Z. Q. Wang & H. M. Siragy: Update: role of the angiotensin type-2 (AT(2)) receptor in blood pressure regulation. Curr. Hypertens. Rep. 2000, 2, 198-201.
5. Daemen, M. J., D. M. Lombardi, F. T. Bosman & S. M. Schwartz: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res. 1991, 68, 450-456.
6. Didion, S. P., P. K. Carmines, H. Ikenaga & W. G. Mayhan: Enhanced constrictor responses of skeletal muscle arterioles during chronic myocardial infarction. Amer. J. Physiol. 1997, 273, H1502-H1508.
7. Fang, Z. Y. & T. H. Marwick: Vascular dysfunction and heart failure: epiphenomenon or etiologic agent? Amer. Heart J. 2002, 143, 383-390.
8. Felder, R. B., J. Francis, Z. H. Zhang, S. G. Wei, R. M. Weiss & A. K. Johnson: Heart failure and the brain: new perspectives. Amer. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284, R259-R276.
9. Furuta, H., D. F. Guo & T. Inagami: Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem. Biophys. Res. Commun. 1992, 183, 8-13.
10. Garcha, R. S., P. S. Sever & A. D. Hughes: Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries. Brit. J. Pharmacol. 1999, 127, 1876-1882.
11. Gschwend, S., R. H. Henning, Y. M. Pinto, D. de Zeeuw, W. H. van Gilst & H. Buikema: Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. Brit. J. Pharmacol. 2003, 139, 1317-1325.
12. Holmgren, A., E. Pantev, D. Erlinge & L. Edvinsson: Inhibition of angiotensin II-induced contraction by losartan in human coronary arteries. J. Cardiovasc. Pharmacol. 1998, 32, 662-664.
13. Högestätt, E. D., K. E. Andersson & L. Edvinsson: Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta physiol. scand. 1983, 117, 49-61.
14. Ikenaga, H., N. Ishii, S. P. Didion, K. Zhang, K. G. Cornish, K. P. Patel, W. G. Mayhan & P. K. Carmines: Suppressed impact of nitric oxide on renal arteriolar function in rats with chronic heart failure. Amer. J. Physiol. 1999, 276, F79-F87.
15. Katugampola, S. D. & A. P. Davenport: Changes in ET(A)-, AT1- and AT2-receptors in the phenotypically transformed intimal smooth muscle layer of human atherosclerotic coronary arteries. J. Cardiovasc. Pharmacol. 2000, 36, S395-S396.
16. Kifor, I. & V. J. Dzau: Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circ. Res. 1987, 60, 422-428.
17. Kim, S. & H. Iwao: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 2000, 52, 11-34.
18. Lassegue, B., R. W. Alexander, G. Nickenig, M. Clark, T. J. Murphy & K. K. Griendling: Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol. Pharmacol. 1995, 48, 601-609.
19. Makita, N., N. Iwai, T. Inagami & K. F. Badr: Two distinct pathways in the down-regulation of type-1 angiotension II receptor gene in rat glomerular mesangial cells. Biochem. Biophys. Res. Commun. 1992, 185, 142-146.
20. Malmsjö, M., M. Adner, T. K. Harden, W. Pendergast, L. Edvinsson & D. Erlinge: The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Brit. J. Pharmacol. 2000, 131, 51-56.
21. Marin, J.: Age-related changes in vascular responses: a review. Mech. Ageing Dev. 1995, 79, 71-114.
22. Masaki, H., T. Kurihara, A. Yamaki, N. Inomata, Y. Nozawa, Y. Mori, S. Murasawa, K. Kizima, K. Maruyama, M. Horiuchi, V. J. Dzau, H. Takahashi, T. Iwasaka, M. Inada & H. Matsubara: Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J. Clin. Invest. 1998, 101, 527-535.
23. Matsubara, H.: Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ. Res. 1998, 83, 1182-1191.
24. Miller, A. A., I. L. Megson & G. A. Gray: Inducible nitric oxide synthase-derived superoxide contributes to hypereactivity in small mesenteric arteries from a rat model of chronic heart failure. Brit. J. Pharmacol. 2000, 131, 29-36.
25. Pantev, E., E. Stenman, A. Wackenfors, L. Edvinsson & M. Malmsjo: Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries. Eur. J. Heart Fail. 2002, 4, 699-705.
26. Simon, G. & S. Altman: Subpressor angiotensin II is a bifunctional growth factor of vascular muscle in rats. J. Hypertens. 1992, 10, 1165-1171.
27. Stassen, F. R., G. E. Fazzi, P. J. Leenders, J. F. Smits & J. G. De Mey: Coronary arterial hyperreactivity and mesenteric arterial hyporeactivity after myocardial infarction in the rat. J. Cardiovasc. Pharmacol. 1997, 29, 780-788.
28. Touyz, R. M. & E. L. Schiffrin: Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 2000, 52, 639-672.
29. Tsuzuki, S., T. Ichiki, H. Nakakubo, Y. Kitami, D. F. Guo, H. Shirai & T. Inagami: Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor. Biochem. Biophys. Res. Commun. 1994, 200, 1449-1454.
30. Weber, K. T.: Fibrosis and hypertensive heart disease. Curr. Opin. Cardiol. 2000, 15, 264-272.
31. Ytterberg, H. & L. Edvinsson: Characterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries. J. renin-angiotensin-aldosterone system 2001, 2, 37-41.
32. Zimmerman, M. C. & R. L. Davisson: Redox signaling in central neural regulation of cardiovascular function. Prog. Biophys. Mol. Biol. 2004, 84, 125-149.